Michael Todisco

Michael Todisco is a declared insider of Dusa Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 29 filings; the first trade dates from 9 May 2008 and the latest from 20 December 2012.

Every open-market trade on record is a sale: 11 sales worth €115k. The rest of the record consists of 15 share grants and 1 option exercise.

The record was last updated on 20 December 2012 with a transaction (€806k) in Dusa Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.